-
The Hospice Payment System Fact Sheet, which offers providers information about the Medicare hospice benefit, is now available from the Centers for Medicare & Medicaid Services (CMS) Medicare Learning Network.
-
In one of the largest studies of its kind, researchers from the Columbia University Mailman School of Public Health assessed the risk of exposure to bloodborne pathogens among nonhospital-based registered nurses (RNs), and found that nearly one out of 10 of the more than 1,100 nurse participants reported at least one needlestick injury in the previous 12 months.
-
A nurse in Philadelphia has admitted that he removed body parts from 244 corpses and then helped forge the paperwork that would allow those parts to be transplanted.
-
Although patient care is the No. 1 priority for hospice managers and staff members, a growing number of health care employees are recognizing that their workday activities can affect more than a patient's health — they can affect the environment.
-
"I don't want to go to no stupid funeral." These words uttered by a key character in a puppet show convinced Penne Williams, LCSW, an instructor at University of South Florida at Lakeland, that the puppet show used by LifePath Hospice and Palliative Care in Tampa, FL, is exactly what is needed to help many children handle their grief.
-
Four years of a program focused on partnerships with long-term care facilities and contracts with 88 different facilities has taught the staff at Hospice Care in Madison, WI, a few tricks on how best to manage multiple relationships in different areas.
-
The Centers for Medicare & Medicaid Services (CMS) has issued a revision to Transmittal 1304 (Change Request 5567) which was titled "Reporting of Additional Data to Describe Services on Hospice Claims."
-
The following guidelines are recommended by the Drug and Food Administration (FDA) for disposal of medications.
-
Amic; Arbor Surgical Technologies; Medtronic; CV Therapeutics; Medlogics Device; St. Jude Medical; HealthTrust Purchasing Group; Masimo
-
As if a huge debt, a sagging share price, weakened sales and a variety of regulatory problems arent enough, a jury has ordered Boston Scientific (Natick, Massachusetts) to pay $431 million in damages to Dr. Bruce Saffran, a New Jersey radiologist who charged that the medical device maker's drug-eluting stents (DES) infringe a patent that he received in 1997.
